Breast
Cancer Res Treat 1999, 55: 213–221.CrossRefPubMed 23. Cortesi L, Turchetti D, Marchi I, Fracca A, Canossi B, Rachele B, Silvia R, Rita PA, Pietro T, Massimo F: Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. Captisol nmr BMC Cancer 2006, 17: 210.CrossRef 24. Caruso A, Di Francesco B, Pugliese P, Cinanni V, Corlito A: Information and awareness of diagnosis and progression of cancer in adult and elderly cancer patients Tumori. J Exp Clini Oncology 2000, 86: 199–203. 25. Caruso A, Bongiorno L, Vallini I, Russo P, Tomao F, Grandinetti ML: Breast Cancer and Distress Resulting from Magnetic Resonance Imaging (MRI): the impact of a psychological intervention of
emotional and informative support. J Exp Clin Cancer Res 2006, 25: 499–505.PubMed 26. Lerman C, Lustbader E, Rimer B: Effects of Individualized Breast Cancer Risk Counseling: a randomized trial. J Natl Cancer Inst 1995, 87: 286–292.CrossRefPubMed 27. Ehus D: Cancer Gene Software (Version 4.3) (computer software). Dallas, TX: UT Southwestern AZD4547 Medical Center at Dallas; 2006. 28. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E: Probability of carrying a mutation of breast-ovarian RepSox supplier cancer gene BRCA 1 based on family history. J Natl Cancer Inst 1997, 89: 227–237.CrossRefPubMed 29. Frank TS, Manley SA, Olopade OI, Cummings S, Garber JE, Bernhardt B, Antman K, Russo D, Wood ME, Mullineau L, Isaacs C, Peshkin B, Buys S, Venne V, Rowley PT, Loader S, Offit K, Robson M, Hampel H, Brener D, Winer EP, Clark S, Weber B, Strong LC, Thomas A, et al.: Sequence analysis of BRCA1 and BRCA2: correlations of mutations with family history and ovarian cancer risk. J Clin Oncol 1998, 16: 2417–2425.PubMed 30. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL: BRCA 2 germ-line
mutations in male breast cancer cases and breast cancer families. Nat Genet 1996, 13: 123–125.CrossRefPubMed 31. Zigmond AS, Snaith RP: The Hospital Anxiety and Depression MycoClean Mycoplasma Removal Kit Scale. Acta Psychiatr Scand 1983, 67: 361–370.CrossRefPubMed 32. Costantini M, Musso M, Viterbori P, Bonci F, Del Mastro L, Garrone O, Venturini M, Morasso G: Detecting psychological distress in cancer patients: validity of the Italian version of the Hospital Anxiety and Depression Scale. Support Care Cancer 1999, 7: 121–127.CrossRefPubMed 33. Bluman LG, Rimer BK, Berry DA, Borstelmann N, Iglehart JD, Regan K, Schildkraut J, Winer EP: Attitudes knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 1999, 17: 1999–104. 34. Cohen J: A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20: 37–46.CrossRef 35.